FDA Drug Application (072022) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by AM THERAP

Back to FDA Applications sponsored by AM THERAP

Application Number072022
Product Number001
FormTABLET;ORAL
Dosage50MG;75MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TRIAMTERENE5


Back to FDA Applications sponsored by AM THERAP